Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of secukinumab in ankylosing spondylitis (AS) and psoriatic arthritis (PsA)-comorbidities and extraarticular manifestations in Real world

Next Previous
Search
Trial Profile

Study of secukinumab in ankylosing spondylitis (AS) and psoriatic arthritis (PsA)-comorbidities and extraarticular manifestations in Real world

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Jun 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Secukinumab (Primary)
  • Indications Ankylosing spondylitis; Psoriatic arthritis
  • Focus Adverse reactions

    • Most Recent Events

    • 15 Jun 2019 Interim results assessing efficacy in a subgroup of ankylosing spondylitis presented at the 20th Annual Congress of the European League Against Rheumatism.
    • 15 Jun 2019 Interim results assessing efficacy in a subgroup of psoriatic arthritis patients, presented at the 20th Annual Congress of the European League Against Rheumatism.
    • 24 Oct 2018 Interim results (n=486) evaluating the incidence of selected extraarticular manifestations and comorbidities at baseline and the impact of secukinumab on the status of these attributes compared to baseline, presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top